Clinical Trial Update: Pediatric Zylet Safety and Efficacy Study [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial evaluated safety and efficacy of Zylet (tobramycin and loteprednol etabonate) for chalazion and hordeolum; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chalazion
• Hordeolum

Drugs mentioned

• Zylet (loteprednol etabonate and tobramycin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Chalazion, Hordeolum | Phase 4 | Status: COMPLETED | Results posted: 2010-09-22